Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of Shanghai Pharmaceuticals Holding Co.,Ltd.

Client Virtual Booth
  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Shanghai Pharmaceuticals Holding Co.,Ltd
China Flag
Country
Country
China
Address
Address
No.200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai 200 020
Telephone
Telephone
+86 216 373 0908
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

left grey arrow
right gray arrow

Details:

The BIOCAD and Shanghai Pharmaceuticals Holding joint venture has announced enrollment of patient with treatment prolgolimab in BCD-100-3/DOMAJOR clinical trial of an original anti-PD1 check point inhibitor in patients with non-small cell lung cancer (NSCLC) by BIOCAD.


Lead Product(s): BCD-100,Pemetrexed,Cisplatin

Therapeutic Area: Oncology Product Name: BCD-100

Highest Development Status: Phase IIIProduct Type: Large molecule

Recipient: Biocad

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable October 13, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY